# Correction to: Increased RTN3 phenocopies nonalcoholic fatty liver disease by inhibiting the AMPK‐IDH2 pathway

**Authors:** Hao Huang, Shuai Guo, Ya‐Qin Chen, Yu‐Xing Liu, Jie‐Yuan Jin, Yun Liang, Liang‐Liang Fan, Rong Xiang

PMC · DOI: 10.1002/mco2.466 · MedComm · 2024-02-04

## Full-text entities

- **Genes:** PRKAA2 (protein kinase AMP-activated catalytic subunit alpha 2) [NCBI Gene 5563] {aka AMPK, AMPK2, AMPKa2, PRKAA}, RTN3 (reticulon 3) [NCBI Gene 10313] {aka ASYIP, HAP, NSPL2, NSPLII, RTN3-A1}, IDH2 (isocitrate dehydrogenase (NADP(+)) 2) [NCBI Gene 3418] {aka D2HGA2, ICD-M, IDH, IDH-2, IDHM, IDP}
- **Diseases:** nonalcoholic fatty liver disease (MESH:D065626)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC10838671/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC10838671/full.md

## References

1 references — full list in the complete paper: https://tomesphere.com/paper/PMC10838671/full.md

---
Source: https://tomesphere.com/paper/PMC10838671